Promega Corporation

Multiplexed Viability Cytotoxicity And Apoptosis Assays For Cell-Based Screening

  • Share
  • Print
  • Email
  • Download PDF
  • Article
  • Comments & Ratings

Abstract

Previously, we introduced the MultiTox-Fluor Multiplex Cytotoxicity Assay technology as a novel means for determining the relative number of live and dead cells in culture. In this article, we demonstrate that the assay technology is sufficiently scalable, sensitive and robust to be multiplexed with other downstream assays to increase the quality of screening data.

Cell Notes 16, 12–15.

Andrew Niles1, Tracy Worzella1, Michael Scurria2, William Daily2, Laurent Bernad2, Pam Guthmiller1, Brian McNamara1, Kay Rashka1, Deborah Lagne1, and Terry L. Riss1

1Promega Corporation, 2Promega Biosciences, Inc.
Publication Date: 2006

Download Article (225 KB)

Prefer a different language?

Your country is set to Austria. Your language is set to Deutsch. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.